<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="Vitalant Research Institute, San Francisco, CA, United States of America[3]," exact="University of California" post="San Francisco, San Francisco, CA, United States of America[4],"/>
 <result pre="California San Francisco, San Francisco, CA, United States of America[4]," exact="Public Health England," post="London, United Kingdom[5], Facente Consulting, Richmond, CA, United States"/>
 <result pre="Data First Consulting, Belmont, CA, United States of AmericaPetersRemco PHEditor[]," exact="University of Pretoria," post="SOUTH AFRICA Competing Interests: M.P.B., E.G., S.N.F., D.H., A.W."/>
 <result pre="HIV Incidence Assays (CEPHIA) was supported by grants from the" exact="Bill and Melinda Gates Foundation" post="(OPP1017716 to G.M., OPP1062806 to C.D.P. and OPP1115799). Additional"/>
 <result pre="for analysis was provided by a grant from the US" exact="National Institutes of Health" post="(R34 MH096606 to C.D.P.) and by the South African"/>
 <result pre="the South African Department of Science and Technology and the" exact="National Research Foundation." post="Specimen and data collection were funded in part by"/>
 <result pre="NIAID, National Institutes of Child Health and Human Development (NICH/HD)," exact="National Institute on Drug Abuse," post="National Institute of Mental Health, and Office of AIDS"/>
 <result pre="Health and Human Development (NICH/HD), National Institute on Drug Abuse," exact="National Institute of Mental Health," post="and Office of AIDS Research, of the NIH, DHHS"/>
 <result pre="Institute on Drug Abuse, National Institute of Mental Health, and" exact="Office of AIDS Research," post="of the NIH, DHHS (UM1 AI068613 and R01 AI095068);"/>
 <result pre="HIV-1 Research Program (RN07-SD-702); Brazilian Program for STD and AIDS," exact="Ministry of Health" post="(914/BRA/3014-UNESCO); and the São Paulo City Health Department (2004-0.168.922–"/>
 <result pre="São Paulo City Health Department (2004-0.168.922– 7). Selected samples from" exact="International AIDS Vaccine Initiative" post="(IAVI)-supported cohorts were funded by IAVI with the generous"/>
 <result pre="Inc., which received salary support for this project from the" exact="Bill and Melinda Gates Foundation" post="through grant OPP1115799 to FIND (Geneva, Switzerland). The funder"/>
 <result pre="Limiting Antigen Avidity EIA (LAg Assay), developed by the US" exact="Centers for Disease Control and Prevention" post="(CDC) [7]. It has been used in major population-level"/>
 <result pre="study, and the requirement for informed consent was waived; the" exact="University of California," post="San Francisco Human Research Protection Program and IRB (formerly"/>
 <result pre="PLOS ONE. 2017;12(2):1–10. 10.1371/journal.pone.0172283 26WHO. HIV drug resistance report 2017." exact="World Health Organization;" post="2017. Available from: https://www.who.int/hiv/pub/drugresistance/hivdr-report-2017/en/. 27Duke Human Vaccine Institute. EQAPOL"/>
</results>
